Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMKR vs GSK✓SelectedUSD · GSKAMKR vs GSK performance historyLatest closeAs of-2.72%11/13
Stock and ETF performance explorer

AMKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.2%
GSK return
+44.4%
Excess return
+20.8%
Maximum drawdown
-67.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%+0.5%-3.2%-2.7%
7D+10.0%+1.1%+8.9%+10.0%
30D-19.4%+6.3%-25.8%-19.6%
3M-37.4%+1.8%-39.2%-37.4%
6M-51.5%+1.7%-53.1%-51.8%
YTD-8.1%+6.5%-14.6%-9.5%
1Y+13.8%+9.5%+4.3%+11.6%
3Y+59.4%+65.3%-5.9%+43.7%
All+65.2%+44.4%+20.8%+38.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling